Dr. Prakash Patil is Associate Professor G-II at the Central Research Laboratory located at K.S. Hegde Medical Academy, NITTE (Deemed to be University), Mangalore, Karnataka, India. He has obtained PhD in Medicine from Japan and Post-Doctoral experience in Medical Pharmacology from South Korea. He has 20 years of research experience in Molecular Cell Biology, Biotechnology and guided sizable, inter-disciplinary masters’ students. He is expertise in derivation of primary cell cultures from human and mouse tissues, development of cell lines and also experienced in conducting experiments using various cell line and animal models.
I have published several papers on PCOS especially identifying the role of miRNAs in regulating the expression HSD17B1 steroid hormone. Dr. Patil is highly competent to conduct in-vitro cell line model molecular mechanism studies and confirm it in the animal model. Overall, he is having sound knowledge in biotechnology and molecular cell biology with an exposure to practices of genome editing using CRISPR-Cas9 system. He is having 75 research publications in good impact and indexed journals.
Dr. Prakash Patil is Associate Professor G-II at the Central Research Laboratory located at K.S. Hegde Medical Academy, NITTE (Deemed to be University), Mangalore, Karnataka, India. He has obtained PhD in Medicine from Japan and Post-Doctoral experience in Medical Pharmacology from South Korea. He has 20 years of research experience in Molecular Cell Biology, Biotechnology and guided sizable, inter-disciplinary masters’ students. He is expertise in derivation of primary cell cultures from human and mouse tissues, development of cell lines and also experienced in conducting experiments using various cell line and animal models.
I have published several papers on PCOS especially identifying the role of miRNAs in regulating the expression HSD17B1 steroid hormone. Dr. Patil is highly competent to conduct in-vitro cell line model molecular mechanism studies and confirm it in the animal model. Overall, he is having sound knowledge in biotechnology and molecular cell biology with an exposure to practices of genome editing using CRISPR-Cas9 system. He is having 75 research publications in good impact and indexed journals.